Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Candesartan Reduces Chronic Heart Failure: ESC Meeting
September 8, 2003
- BI to Further Collaborate with Japanese Firms: Prof. Krebs
September 1, 2003
- REGULATORY NEWS IN BRIEF
September 1, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 1, 2003
- ON THE MOVE
September 1, 2003
- Dainippon to Promote Better Cancer Pain Management
September 1, 2003
- Don Quijote to Provide Free OTC Drugs in Late Night Emergencies
September 1, 2003
- Merck & Co. Determined to Acquire All Shares of Banyu
September 1, 2003
- Anti-fatigue Food, Drug Development Project to Start from October: Soiken
September 1, 2003
- Antitumor Drug TZT-1027 Could Be Major Global Product: Teikoku Hormone
September 1, 2003
- G&G Enters Capital, Business Tie-up with Toyo Pharmar
September 1, 2003
- Kaken Considers Global Development with Fiblast
September 1, 2003
- Shipment of PPA-containing OTC Drugs Stopped
September 1, 2003
- Neoral Patent Litigation Between Novartis and Merck Hoei Continues
September 1, 2003
- BULLETIN
September 1, 2003
- Kyowa, Kyorin to Copromote Allelock to Facilities with Less than 100 Beds
September 1, 2003
- OTC NEWS IN BRIEF
September 1, 2003
- BUSINESS NEWS IN BRIEF
September 1, 2003
- DIAGNOSTIC NEWS IN BRIEF
September 1, 2003
- WEBSITE NEWS
September 1, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…